Have a question or topic idea for The Life Science Report? Submit it here.
Antimicrobials Antifungals Investment Landscape
Drs. Peter Bak and Jonathan Gertler discuss the current landscape of anti-infectives, antimicrobials & antifungals, including:
How commercial dynamics drive clinical unmet need
The role the pandemic played on development & investments
The deployment of cell therapies for viral diseases
Foundation support for anti-infectives
“Push incentives” to usher therapies into commercial stages
Read Dr. Peter Bak's article in STAT News, “Investment in antimicrobials was up in 2020, but much work remains.”
Subscribe to Back Bay's Life Science Report podcast on any major podcast player. Please join the conversation: send us your comments and questions.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher
